| Literature DB >> 35624823 |
Cornelia-Ioana Ilie1,2, Eliza Oprea3,4, Elisabeta-Irina Geana5, Angela Spoiala1,2, Mihaela Buleandra6, Gratiela Gradisteanu Pircalabioru7, Irinel Adriana Badea6, Denisa Ficai2,8, Ecaterina Andronescu1,2,9, Anton Ficai1,2,9, Lia-Mara Ditu3,7.
Abstract
This paper evaluated the chemical and biological properties of bee pollen samples from Romania. Firstly, the bee pollen alcoholic extracts (BPEs) were obtained from raw bee pollen harvested by Apis mellifera carpatica bees. The chemical composition of BPE was obtained by determination of total phenol content and total flavonoid content, UHPLC-DAD-ESI/MS analysis of phenolic compounds, and GC-MS analysis of fatty acids, esters, and terpenes. Additionally, the antioxidant activity was evaluated by the Trolox Equivalent Antioxidant Capacity method. Furthermore, the biological properties of BPE were evaluated (antimicrobial and cytotoxic activity). The raw BP samples studied in this paper had significant phenolic acid and flavonoid content, and moderate fatty acid, ester, and terpene content. P1, P2, and P4 have the highest TPC and TFC levels, and the best antioxidant activity. All BPEs studied had antimicrobial activity on pathogenic strains isolated from the clinic or standard strains. A synergistic antimicrobial effect of the BPEs was observed along with the soluble compounds of L. rhamnosus MF9 and E. faecalis 2M17 against some pathogenic (clinical) strains and, considering the tumour proliferation inhibitory activity, makes BP a potential prebiotic and antitumour agent for the gut environment.Entities:
Keywords: antimicrobial activity; bee pollen; phenolic compounds; prebiotics; tumour proliferation inhibitory agents
Year: 2022 PMID: 35624823 PMCID: PMC9137718 DOI: 10.3390/antiox11050959
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Origin of bee pollen samples.
| Sample | Flowering Plants | Date of Harvest |
|---|---|---|
| P1 | 1 April 2020 | |
| P2 | 10 April 2020 | |
| P3 | 24 April 2020 | |
| P4 | 1 May 2020 | |
| P5 | 1 June 2020 |
The moisture content.
| Sample | Moisture (%) ± SD |
|---|---|
| P1 | 27.83 ± 0.01 a |
| P2 | 22.62 ± 0.02 a |
| P3 | 26.47 ± 0.01 a |
| P4 | 31.91 ± 0.02 a |
| P5 | 35.87 ± 0.02 a |
We compared the differences between samples using RM one-way ANOVA and Tukey’s multiple comparisons test. The p-value for all samples was <0.0001 and is represented in the table by a.
Total phenol content, total flavonoid content, and antioxidant activity.
| Sample | TPC (GAE) 1 | TFC (QE) 2 | TEAC 3 |
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| P3 | 13.24 ± 0.01 d | 0.20 ± 0.02 d | 0.04 ± 0.02 d |
|
|
|
|
|
| P5 | 10.77 ± 0.02 d | 0.19 ± 0.01 d | 0.03 ± 0.01 a,d |
1 TPC expressed as mg gallic acid/g BP; 2 TFC expressed as mg quercetin/g BP; and 3 TEAC expressed as mmol Trolox/g BP. We compared differences between the resulting TPC, TFC, and antioxidant assays of all BPEs using one-way ANOVA and Tukey’s multiple comparisons tests. a, b, c and d letters indicate significant differences between samples (a p < 0.05; b p < 0.007; c p = 0.0001; d p < 0.0001).
The phenolic acid and flavonoid concentrations from BP (µg/g).
| Phenolic Compound | Sample | ||||
|---|---|---|---|---|---|
| P1 | P2 | P3 | P4 | P5 | |
|
| |||||
| gallic acid | 0.015 | 0.087 | 0.157 | 0.075 |
|
| 3,4-dihydroxybenzoic acid | 0.254 | 0.401 | 0.454 | 0.209 |
|
| 4-hydroxybenzoic acid | 7.603 |
| 8.455 | 4.458 | 2.685 |
| chlorogenic acid | 0.733 | 2.441 | 6.481 |
| 0.275 |
| caffeic acid | 0.404 | 0.471 | 0.734 |
| 0.275 |
| syringic acid | 0.090 | ND | ND | ND |
|
| 1.227 | 1.151 | 1.153 |
| 1.036 | |
| ferulic acid |
|
| 0.961 | 1.271 | 1.199 |
| cinnamic acid # | 0.898 | 0.227 |
| 1.286 | 0.400 |
|
| |||||
| epicatechin | 0.868 | 1.029 | 0.070 |
| 0.137 |
| catechin |
| 0.959 | 0.332 | 0.224 | 0.587 |
| rutin | 45.662 | 1.691 |
| 69.451 | ND |
| myricetin |
| 0.506 | 0.052 | 0.224 | 0.012 |
| quercetin | 3.577 | 1.639 | 3.214 |
|
|
| kaempferol | 2.155 | 1.308 | 7.337 | 8.676 |
|
| isorhamnetin | 3.502 | 0.558 | 12.141 | 5.086 |
|
| apigenin | 0.015 | 0.052 | 0.070 | 0.165 |
|
| pinocembrin | 0.644 |
| 0.559 | 1.227 | 0.412 |
| galangin | ND |
| 0.017 | 0.239 | 0.175 |
| chrysin | 0.464 |
| 0.384 | 0.853 | 0.387 |
ND (not detected) Naringenin, hesperidin, pinostrombin, and resveratrol were not detected in the bee pollen samples. # p-coumaric, ferulic, caffeic, and chlorogenic acids are derivatives of cinnamic acid (which does not contain phenolic groups), and for this reason it was still included in the table.
Processed BPE composition.
| Compounds | RI a | RA b (%) | ||||
|---|---|---|---|---|---|---|
| P1 | P2 | P3 | P4 | P5 | ||
| Isophorone | 1132 | ND | ND | ND | ND |
|
| Lilac aldehyde A | 1149 |
|
| ND | ND | ND |
| Lilac aldehyde B | 1159 |
|
| ND | ND | ND |
| Lilac aldehyde D | 1174 |
|
| ND | ND | ND |
| Caprylic acid | 1181 | ND | ND |
| ND | ND |
| Lilac alcohol B | 1222 |
|
| ND | ND | ND |
| Lilac alcohol D | 1237 |
|
| ND | ND | ND |
| 5-Hydroxymethylfurfural | 1245 | ND | ND |
| ND | ND |
| 1499 |
|
|
|
|
| |
| 2,4-Di-tert-butylphenol | 1521 |
|
|
|
|
|
| Dodecanoic acid | 1568 | ND | ND |
| ND | ND |
| Globulol | 1572 | ND | ND |
| ND |
|
| Methoxyeugenol | 1619 | ND | ND | ND | ND |
|
| Myristic acid | 1762 | ND |
| ND |
|
|
| Benzoic acid, phenylmethyl ester | 1787 | ND | ND |
|
|
|
| Myristic acid, isopropyl ester | 1824 |
|
|
| ND |
|
| Pentadecanoic acid ethyl ester | 1881 |
|
|
| ND | ND |
| 7,9-Di-tert-butyl-1-oxaspiro(4,5)deca-6,9-diene-2,8-dione | 1940 |
|
|
|
|
|
| Palmitic acid | 1968 |
|
|
|
|
|
| Palmitic acid, ethyl ester | 1996 |
|
|
|
|
|
| 9,12,15-Octadecatrienoic acid, methyl ester | 2084 | ND | ND |
| ND | ND |
| Linoleic acid, methyl ester | 2090 | ND | ND |
| ND | ND |
| Linolenic acid, methyl ester | 2096 |
|
|
|
|
|
| Linolenic acid | 2107 |
|
|
|
|
|
| Linoleic acid | 2112 |
|
|
|
|
|
| Linolenic acid, methyl ester | 2119 |
|
|
|
|
|
| Stearic acid, methyl ester | 2126 |
|
| ND |
|
|
| Stearic acid, ethyl ester | 2222 | ND |
| ND | ND |
|
| Unidentified compounds | - | 1.41 | 0.00 | 2.36 | 0.00 | 9.34 |
|
| - |
|
|
|
|
|
| Fatty acids and esters | - |
|
|
|
|
|
| Terpenes and terpenoides | - |
|
|
|
|
|
ND (not detected) a RI = Kovats index, measured relative to n-alkanes (C8–C20) on a DB-5MS capillary column; b RA = relative area (%) = relative contents expressed as percentages of the total compounds.
The growth inhibition zone diameters (GIZD).
| Strain | GIZD (mm) | |||||
|---|---|---|---|---|---|---|
| P1 | P2 | P3 | P4 | P5 | CEt | |
|
| ||||||
| 1. |
| 13.50 ± 0.50 b | 11.50 ± 0.50 a |
| 11.50 ± 0.50 b | 7.00 ± 1.00 |
| 2. | 13.00 ± 0.50 b | 13.00 ± 1.00 a | 12.00 ± 0.23 | 13.00 ± 0.35 b |
| 9.70 ± 0.60 |
|
| ||||||
| 1. |
| 14.30 ± 0.57 a | 13.30 ± 0.25 | 13.00 ± 0.06 | 14.00 ± 0.45 a | 12.00 ± 1.00 |
| 2. | 14.50 ± 0.50 a |
| 14.90 ± 0.90 a | 14.40 ± 0.20 a | 14.50 ± 0.50 a | 12.70 ± 0.60 |
| 3. |
|
| 10.90 ± 0.15 | 10.80 ± 0.15 |
| 9.70 ± 0.60 |
|
| ||||||
| 1. | 15.10 ± 0.15 | 14.70 ± 0.07 | 15.10 ± 0.17 |
|
| 14.40 ± 0.15 |
| 2. |
|
|
| 16.90 ± 0.15 | 16.20 ± 0.50 | 16.50 ± 0.50 |
| 3. |
|
| 14.50 ± 0.25 | 14.50 ± 0.25 | 14.40 ± 0.17 | 14.00 ± 1.00 |
| 4. |
| 17.50 ± 0.05 b | 17.10 ± 0.15 a | 16.90 ± 0.11 b |
| 16.00 ± 0.05 |
| 5. | 16.20 ± 0.25 a | 16.40 ± 0.10 a | 16.90 ± 0.15 a |
| 16.00 ± 0.25 a | 12.50 ± 0.50 |
| 6. |
| 16.50 ± 0.10 a | 16.50 ± 0.25 a | 15.50 ± 0.25 | 16.10 ± 0.10 a | 14.50 ± 0.50 |
The significant impact of the BPEs on each microbial strain was statistically analysed by one-way ANOVA and Dunnett’s multiple comparisons post hoc test. The resulting data were statistically significant. Different letters indicate the significant differences between samples and CEt (a p < 0.05; b p < 0.01; c p < 0.001; d p < 0.0001).
Determination of MIC values (µg/mL).
| Strain | MIC | ||||
|---|---|---|---|---|---|
| P1 | P2 | P3 | P4 | P5 | |
|
| |||||
| 1. |
| 2150 | 4290 | 2510 | 3000 |
| 2. |
|
| 2150 |
|
|
|
| |||||
| 1. | 2510 | 2150 |
| 2510 |
|
| 2. | 1250 |
|
| 1250 | 1500 |
| 3. |
|
|
| 1250 | 1500 |
|
| |||||
| 1. | 5010 | 2150 | 4290 |
|
|
| 2. |
| 2150 |
| 2510 | 3000 |
| 3. |
|
|
|
| 3000 |
| 4. |
| 2150 | 2150 |
|
|
| 5. | 2510 |
|
|
| 3000 |
| 6. |
| 2150 |
| 2510 | 3000 |
Determination of minimal concentration for biofilm eradication (MCBE) values (µg/mL).
| Strain | MCBE | ||||
|---|---|---|---|---|---|
| P1 | P2 | P3 | P4 | P5 | |
|
| |||||
| 1. |
| 2.150 | 2150 | 2510 | 3000 |
| 2. |
|
| 2150 |
|
|
|
| |||||
| 1. |
|
|
| 2510 | 1500 |
| 2. | 2510 |
|
| 1250 | 1500 |
| 3. |
|
|
|
| 1500 |
|
| |||||
| 1. | 2510 | 2150 | 2150 |
|
|
| 2. |
| 2150 |
| 2510 | 3000 |
| 3. |
|
|
|
| 3000 |
| 4. |
| 2150 | 2150 |
|
|
| 5. | 2510 |
|
|
|
|
| 6. |
| 2150 |
| 2510 | 3000 |
Figure 1Graphic representation of AI% values representing the influence of BPE on adherence capacity of Gram-positive bacteria; (P1–P5)-BPE samples; (C+)-bacterial adherence control. The differences between antibacterial activity of BPE samples and bacterial adherence control were statistically analysed by performing one-way ANOVA, followed by Dunnett’s multiple comparisons. (** p < 0.005; *** p < 0.001; **** p < 0.0001).
Figure 2Graphic representation of AI% values representing the influence of BPE on the adherence capacity of Gram-negative bacteria; (P1–P5)-BPE samples; (C+)-bacterial adherence control. The significant impact of the BPE on the adherence capacity of E. cloacae and P. aeruginosa was tested by performing one-way ANOVA and Dunnett’s multiple comparisons tests. All data were considered statistically significant. (* p < 0.05; ** p < 0.01; *** p < 0.001).
Figure 3Graphic representation of AI% values representing the influence of BPE on the adherence capacity of yeast strains; (P1–P5)-BPE samples; (C+)-yeast adherence control. The antimicrobial effect of BPE on yeast strains was compared using one-way ANOVA and Dunnett’s multiple comparisons tests. The results were considered statistically significant. (ns—not significant; * p < 0.05; ** p < 0.01; **** p < 0.0001).
Figure 4Graphic representation of AI% values representing the influence of BPE on the adherence capacity of the bacterial strains with probiotic potential; (P1–P5)-BPE samples; (C+)-bacterial adherence control. The significant impact of the effect of BPE on lactic strains was statistically analysed through one-way ANOVA and Dunnett’s multiple comparisons tests. (ns—not significant; * p ≤ 0.01; *** p < 0.001; **** p < 0.0001).
Figure 5Graphic representation of CFU/mL values representing the influence of BPE on the bacterial growth of Lactobacillus rhamnosus MF9; (P1–P5)-BPE samples; (C+)-L. rhamnosus MF9 growth control. The prebiotic effect of BPE on L. rhamnosus MF9 growth was statistically analysed in one-way ANOVA and Dunnett’s multiple comparisons tests. The data is considered statistically significant. (ns—not significant; * p < 0.05; ** p < 0.007).
Figure 6Graphic representation of CFU/mL values representing the influence of BPE on the bacterial growth of Enterococcus faecalis 2M17; (P1–P5)-BPE samples; (C+)-E. faecalis 2M17 growth control. The prebiotic effect of BPE on E. faecalis 2M17 growth was statistically analysed in one-way ANOVA and Dunnett’s multiple comparisons tests. The data is considered statistically significant. (ns—not significant; * p < 0.05; ** p < 0.08; *** p = 0.0009).
Figure 7Graphic representation of AI% values representing the synergic influence of BPE and probiotic Soluble Compounds (SN) on the adherence capacity of Enterobacter cloacae; (P1–P5)-BPE samples, pathogenic strains adherence control (Cp), pathogenic strains with probiotic supernatant adherence control (CP+SN). The differences between the effects of BPE and soluble compounds of strains on adherence capacity of clinical strains were statistically analysed using one-way ANOVA, followed by Dunnett’s test for multiple comparisons of groups. (** p < 0.01).
Figure 8Graphic representation of AI% values representing the synergic influence of BPE and probiotic Soluble Compounds (SN) on the adherence capacity of Candida guillermondii; (P1–P5)-BPE samples, pathogenic strains adherence control (Cp), pathogenic strains with probiotic supernatant adherence control (CP+SN). The differences between the effects of BPE and soluble compounds of strains on the adherence capacity of clinical yeast strains were statistically analysed using one-way ANOVA. Furthermore, Dunnett’s test for multiple comparisons of groups was performed. The results were considered statistically significant. (* p < 0.05; ** p < 0.009).
Figure 9(a) Graphic representation of the absorbance values to evaluate the influence of BPEs on cell viability, the proliferation of tumoural cells (MTT assay). (b) Graphic representation of the absorbance values to evaluate the cytotoxic effect of BPEs on tumoural cells (LDH assay); (P1–P5) BPE samples, C-cell culture control. The differences between cell viability and proliferation for the MTT assay were statistically analysed using one-way ANOVA followed by Dunnett’s multiple comparisons tests. (ns—not significant; ** p < 0.007); The LDH data were statistically analysed in the same way. (ns—not significant; ** p = 0.0013; *** p ≤ 0.0009; **** p < 0.0001).